Excerpt: The strategy document describes the draft framework for CMS' review of Medicare prescription drug plan formularies. It also provides a strategy for drug benefit review that promotes appropriate operation of beneficiary protections and formulary oversight that includes access to all Part D covered drugs, while providing flexibility in plan design as expected under the Medicare Modernization Act (MMA). Comments should be sent to drugbenefitimpl@cms.hhs.gov by Dec. 30, 2004.

MORE >>